A Study to Determine the Efficacy and Safety of Fasinumab for the Treatment of Adults With Chronic Low Back Pain
Clinical trial NCT02620020 · COMPLETED
Trial details
- NCT number
- NCT02620020
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-26
- Primary completion
- 2017-02-03
- Enrollment
- 563
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.